Cargando…
Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation
Background. Atrial fibrillation (AF) increases the risk for stroke but also for non-stroke major adverse cardiovascular events (MACE). The 2MACE score was recently proposed to predict these events. Since the interest of microRNAs (miRNAs) in cardiovascular diseases is increasing, we aimed to investi...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698124/ https://www.ncbi.nlm.nih.gov/pubmed/33198388 http://dx.doi.org/10.3390/jcm9113645 |
_version_ | 1783615757635026944 |
---|---|
author | Rivera-Caravaca, José Miguel Teruel-Montoya, Raúl Roldán, Vanessa Cifuentes-Riquelme, Rosa Crespo-Matas, José Antonio de los Reyes-García, Ascensión María Águila, Sonia Fernández-Pérez, María Piedad Reguilón-Gallego, Laura Zapata-Martínez, Laura García-Barberá, Nuria Vicente, Vicente Marín, Francisco Martínez, Constantino González-Conejero, Rocío |
author_facet | Rivera-Caravaca, José Miguel Teruel-Montoya, Raúl Roldán, Vanessa Cifuentes-Riquelme, Rosa Crespo-Matas, José Antonio de los Reyes-García, Ascensión María Águila, Sonia Fernández-Pérez, María Piedad Reguilón-Gallego, Laura Zapata-Martínez, Laura García-Barberá, Nuria Vicente, Vicente Marín, Francisco Martínez, Constantino González-Conejero, Rocío |
author_sort | Rivera-Caravaca, José Miguel |
collection | PubMed |
description | Background. Atrial fibrillation (AF) increases the risk for stroke but also for non-stroke major adverse cardiovascular events (MACE). The 2MACE score was recently proposed to predict these events. Since the interest of microRNAs (miRNAs) in cardiovascular diseases is increasing, we aimed to investigate whether miRNA levels may improve the predictive performance of the 2MACE score. Methods. We included consecutive AF patients stable on vitamin K antagonist therapy. Blood samples were drawn at baseline and plasma expression of miRNAs was assessed. During a median of 7.6 (interquartile range (IQR) 5.4–8.0) years, the occurrence of any MACE (nonfatal myocardial infarction/cardiac revascularization and cardiovascular death) was recorded. Results. We conducted a miRNA expression analysis in plasma from 19 patients with and without cardiovascular events. The miRNAs selected (miR-22-3p, miR-107, and miR-146a-5p) were later measured in 166 patients (47% male, median age 77 (IQR 70–81) years) and all were associated with a higher risk of MACE. The addition of miR-107 and miR-146a-5p to the 2MACE score significantly increased the predictive performance (c-indexes: 0.759 vs. 0.694, p = 0.004), and the model with three miRNAs also improved the predictive performance compared to the original score (c-indexes: 0.762 vs. 0.694, p = 0.012). 2MACE models with the addition of miRNAs presented higher net benefit and potential clinical usefulness. Conclusions. Higher miR-22-3p andmiR-107 and lower miR-146a-5p levels were associated with a higher risk of MACE. The addition of these miRNAs to the 2MACE score significantly increased the predictive performance for MACE, which may aid to some extent in the decision-making process about risk stratification in AF. |
format | Online Article Text |
id | pubmed-7698124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76981242020-11-29 Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation Rivera-Caravaca, José Miguel Teruel-Montoya, Raúl Roldán, Vanessa Cifuentes-Riquelme, Rosa Crespo-Matas, José Antonio de los Reyes-García, Ascensión María Águila, Sonia Fernández-Pérez, María Piedad Reguilón-Gallego, Laura Zapata-Martínez, Laura García-Barberá, Nuria Vicente, Vicente Marín, Francisco Martínez, Constantino González-Conejero, Rocío J Clin Med Article Background. Atrial fibrillation (AF) increases the risk for stroke but also for non-stroke major adverse cardiovascular events (MACE). The 2MACE score was recently proposed to predict these events. Since the interest of microRNAs (miRNAs) in cardiovascular diseases is increasing, we aimed to investigate whether miRNA levels may improve the predictive performance of the 2MACE score. Methods. We included consecutive AF patients stable on vitamin K antagonist therapy. Blood samples were drawn at baseline and plasma expression of miRNAs was assessed. During a median of 7.6 (interquartile range (IQR) 5.4–8.0) years, the occurrence of any MACE (nonfatal myocardial infarction/cardiac revascularization and cardiovascular death) was recorded. Results. We conducted a miRNA expression analysis in plasma from 19 patients with and without cardiovascular events. The miRNAs selected (miR-22-3p, miR-107, and miR-146a-5p) were later measured in 166 patients (47% male, median age 77 (IQR 70–81) years) and all were associated with a higher risk of MACE. The addition of miR-107 and miR-146a-5p to the 2MACE score significantly increased the predictive performance (c-indexes: 0.759 vs. 0.694, p = 0.004), and the model with three miRNAs also improved the predictive performance compared to the original score (c-indexes: 0.762 vs. 0.694, p = 0.012). 2MACE models with the addition of miRNAs presented higher net benefit and potential clinical usefulness. Conclusions. Higher miR-22-3p andmiR-107 and lower miR-146a-5p levels were associated with a higher risk of MACE. The addition of these miRNAs to the 2MACE score significantly increased the predictive performance for MACE, which may aid to some extent in the decision-making process about risk stratification in AF. MDPI 2020-11-12 /pmc/articles/PMC7698124/ /pubmed/33198388 http://dx.doi.org/10.3390/jcm9113645 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rivera-Caravaca, José Miguel Teruel-Montoya, Raúl Roldán, Vanessa Cifuentes-Riquelme, Rosa Crespo-Matas, José Antonio de los Reyes-García, Ascensión María Águila, Sonia Fernández-Pérez, María Piedad Reguilón-Gallego, Laura Zapata-Martínez, Laura García-Barberá, Nuria Vicente, Vicente Marín, Francisco Martínez, Constantino González-Conejero, Rocío Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation |
title | Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation |
title_full | Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation |
title_fullStr | Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation |
title_full_unstemmed | Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation |
title_short | Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation |
title_sort | pilot study on the role of circulating mirnas for the improvement of the predictive ability of the 2mace score in patients with atrial fibrillation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698124/ https://www.ncbi.nlm.nih.gov/pubmed/33198388 http://dx.doi.org/10.3390/jcm9113645 |
work_keys_str_mv | AT riveracaravacajosemiguel pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT teruelmontoyaraul pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT roldanvanessa pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT cifuentesriquelmerosa pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT crespomatasjoseantonio pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT delosreyesgarciaascensionmaria pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT aguilasonia pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT fernandezperezmariapiedad pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT reguilongallegolaura pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT zapatamartinezlaura pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT garciabarberanuria pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT vicentevicente pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT marinfrancisco pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT martinezconstantino pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation AT gonzalezconejerorocio pilotstudyontheroleofcirculatingmirnasfortheimprovementofthepredictiveabilityofthe2macescoreinpatientswithatrialfibrillation |